Target intelligence / Profile preview

Rabies virus proteins (N, P, M, G, L (refer to individual proteins; "rabies virus proteins" is not a standard abbreviation))

Target
N, P, M, G, L (refer to individual proteins; "rabies virus proteins" is not a standard abbreviation)
Molecular classification
Viral protein, Enzyme (polymerase L), Structural protein (nucleoprotein N, matrix protein M), Surface protein (glycoprotein G), Accessory protein/chaperone (phosphoprotein P)
01

Overview

Rabies virus proteins are a set of five distinct proteins constituting the structural, enzymatic, and immunogenic components of the rabies virus (genus Lyssavirus, family Rhabdoviridae): nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and polymerase (L). The nucleoprotein encapsidates genomic RNA and is crucial for nucleocapsid formation. The phosphoprotein acts as a cofactor for polymerase and chaperones nucleoprotein. The matrix protein facilitates virus budding and structural stability. The glycoprotein, present as trimeric spikes on the viral envelope, mediates host cell attachment and membrane fusion and is the principal target for neutralizing antibodies and vaccines. The polymerase is responsible for viral RNA synthesis and transcription. While the collective term “rabies virus proteins” is not itself a canonical therapeutic target, individual proteins, notably the glycoprotein, are critical targets for antirabies therapies and prophylaxis.

Other names
Rabies viral proteinsRABV proteinsLyssavirus proteins
02

Mechanism of action

Neutralizing antibodies block virus entry by binding glycoprotein G; Vaccine-induced immunity stimulates antibody response to glycoprotein G; Experimental small molecules may inhibit viral polymerase activity (L)

03

Biological functions

Genome encapsidation (N)Viral RNA synthesis and replication (L, P)Virus assembly and budding (M)Host cell entry and immune response induction (G)Accessory/chaperoning (P)
04

Disease associations

Infection (specifically rabies)Zoonosis
05

Safety considerations

None for molecular targeting per se; general vaccine challenges (potency, allergic reaction)Therapeutic targeting of viral enzymes/proteins may risk viral escape mutations and resistanceSafety of live attenuated vaccines (rare risk of reversion to virulence)
06

Interacting drugs

Rabies human vaccine (targets G protein)

2 more in the full profile.

07

Biomarkers

Anti-rabies virus glycoprotein antibodies (seroconversion, vaccine efficacy)

Beyond the preview

Go deeper on Rabies virus proteins (N, P, M, G, L (refer to individual proteins; "rabies virus proteins" is not a standard abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rabies virus proteins (N, P, M, G, L (refer to individual proteins; "rabies virus proteins" is not a standard abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call